Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schnell

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Concern (Regina, Sask.)|May 2, 1998
What does the public expect from nursing leaders in the reformed health system?M Schnell
The Oncologist|April 17, 2003
Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic controlFrederick M Schnell
Clinical Trials (London, England)|May 1, 2023
Controlling the false-discovery rate when identifying the subgroup benefiting from treatmentPatrick M Schnell
Statistical Methods in Medical Research|December 1, 2020
Monte Carlo approaches to frequentist multiplicity-adjusted benefiting subgroup identificationPatrick M Schnell
Journal of Neurochemistry|July 1, 1977
Uptake and metabolism of 5-methyltetrahydrofolic acid by rat brain slicesM Schnell, L A Ordóñez
Trends in Biochemical Sciences|August 13, 2022
DUB-le vision: snapshots of the proteasome during substrate processingHelena M Schnell, John Hanna
Journal of Virology|February 1, 1994
Rescue of synthetic genomic RNA analogs of rabies virus by plasmid-encoded proteinsK K Conzelmann, M Schnell
The Annals of Applied Statistics|September 2, 2025
BAYESIAN DATA AUGMENTATION FOR RECURRENT EVENTS UNDER INTERMITTENT ASSESSMENT IN OVERLAPPING INTERVALS WITH APPLICATIONS TO EMR DATAXin Liu, Patrick M Schnell
Therapeutic Innovation & Regulatory Science|September 21, 2018
A Bayesian Exposure-Time Method for Clinical Trial Safety Monitoring With Blinded DataPatrick M Schnell, Greg Ball
Current Therapeutic Research, Clinical and Experimental|May 3, 2014
An evaluation of potential signals for ventricular arrhythmia and cardiac arrest with dolasetron, ondansetron, and granisetron in the fda combined spontaneous reporting system/adverse event reporting systemFrederick M Schnell, Andrew J Coop
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Concern (Regina, Sask.)|May 2, 1998
What does the public expect from nursing leaders in the reformed health system?M Schnell
The Oncologist|April 17, 2003
Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic controlFrederick M Schnell
Clinical Trials (London, England)|May 1, 2023
Controlling the false-discovery rate when identifying the subgroup benefiting from treatmentPatrick M Schnell
Statistical Methods in Medical Research|December 1, 2020
Monte Carlo approaches to frequentist multiplicity-adjusted benefiting subgroup identificationPatrick M Schnell
Journal of Neurochemistry|July 1, 1977
Uptake and metabolism of 5-methyltetrahydrofolic acid by rat brain slicesM Schnell, L A Ordóñez
Trends in Biochemical Sciences|August 13, 2022
DUB-le vision: snapshots of the proteasome during substrate processingHelena M Schnell, John Hanna
Journal of Virology|February 1, 1994
Rescue of synthetic genomic RNA analogs of rabies virus by plasmid-encoded proteinsK K Conzelmann, M Schnell
The Annals of Applied Statistics|September 2, 2025
BAYESIAN DATA AUGMENTATION FOR RECURRENT EVENTS UNDER INTERMITTENT ASSESSMENT IN OVERLAPPING INTERVALS WITH APPLICATIONS TO EMR DATAXin Liu, Patrick M Schnell
Therapeutic Innovation & Regulatory Science|September 21, 2018
A Bayesian Exposure-Time Method for Clinical Trial Safety Monitoring With Blinded DataPatrick M Schnell, Greg Ball
Current Therapeutic Research, Clinical and Experimental|May 3, 2014
An evaluation of potential signals for ventricular arrhythmia and cardiac arrest with dolasetron, ondansetron, and granisetron in the fda combined spontaneous reporting system/adverse event reporting systemFrederick M Schnell, Andrew J Coop
Pageof 14